伊索法戈明抑制多种TcdB变种,并保护小鼠免受Clostridioides difficile诱导的死亡
Ashleigh S Paparella1, Isabella Brew1, Huynh A Hong2
1Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York 10461, United States.
ACS infectious diseases
|February 9, 2024
概括
伊索法戈因有效地抑制了多种类型的Clostridioides difficile毒素TcdA和TcdB. 这种广泛的抑制作用可以防止C. difficile感染,并促进肠道微生物群的恢复.
科学领域:
- 微生物学 微生物学
- 毒理学 毒理学 毒理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 困难菌感染 (CDI) 是病房性腹的主要原因.
- 毒素TcdA和TcdB是CDI发病的关键毒性因素.
- 现有疗法需要对新兴毒素变体进行评估.
研究的目的:
- 评估异花胺对多种Clostridioides difficile毒素变异的抑制功效.
- 在CDI的细胞和小鼠模型中评估异胺的保护作用.
- 在CDI期间确定异巴胺对胃肠道微生物群的影响.
主要方法:
- 在体外的酶定量测试以评估异花胺抑制TcdA和TcdB变体.
- 基于细胞的测试评估了对毒素诱导的细胞圆形化的保护.
- 在C. difficile感染的小鼠模型的体内研究.
- 治疗后胃肠道微生物群组成的分析.
主要成果:
- 伊索法戈胺在多种TcdB变异中显示出抑制葡萄糖转酶域.
- 伊索法哥胺保护细胞免受TcdB诱导的细胞圆化.
- 在CDI的小鼠模型中,isofagomine显著降低了死亡率.
- 用异胺治疗促进了肠道微生物群的恢复.
结论:
- 伊索法哥胺对关键的C. difficile毒素表现出广泛的活性.
- 伊索法戈因显示出作为CDI治疗或预防剂的潜力.
- 伊索法哥米因恢复肠道微生物群的能力可能会防止复发性CDI.
更多相关视频
12:58A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
Published on: May 25, 2017
9.0K
09:12A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
Published on: June 15, 2018
10.1K
相关概念视频
Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
